Post-Marketing Surveillance of Acofide in Patients with Functional Dyspepsia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080222794

Enrollment

3000

Registered

2015-02-13

Start date

2015-02-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia

Interventions

investigational material(s) Generic name etc : Acofide tablets 100mg INN of investigational material : Acotiamide Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Adm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: postprandial fullness, upper abdominal bloating, early satiety

Exclusion criteria

Exclusion criteria: malignant disease in upper gastrointestinal tract

Design outcomes

Primary

Measure	Time frame
Safety rate of side effects	—

Secondary

Measure	Time frame
efficacy improvement rate	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026